11 Capital Partners LP Edwards Lifesciences Corp Transaction History

11 Capital Partners LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $3.3 Million - $4.45 Million	47,635 Added 100.58%	94,995 $6.58 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $6.28 Million - $7.28 Million	-77,140 Reduced 61.96%	47,360 $4.47 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $1.11 Million - $1.27 Million	-15,000 Reduced 10.75%	124,500 $10.3 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $9.53 Million - $12.2 Million	139,500 New	139,500 $10.4 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $15.8 Million - $18.9 Million	-153,684 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $9.66 Million - $12.1 Million	-115,222 Reduced 42.85%	153,684 $15.9 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $4.95 Million - $5.71 Million	62,923 Added 30.55%	268,906 $22.5 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $14.8 Million - $18.8 Million	205,983 New	205,983 $18.8 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of 11 Capital Partners LP, based on Form 13F filings with the SEC.

Stay updated on 11 Capital Partners LP with notifications on news.